TROJAN BIO LTD

General Data

supplementary funding
Reg Number
516471208
Sector
Biomed
Established
2021
No. of Employees
8
Stage
R&D
Additional Funding
1

Description

Trojan is developing a novel anti cancer treatment that enables the immune system to fight cancer cells as it does with viruses. Trojan antibodies detect, inhibit, and mark cancer cells as virally infected, signaling the immune system to attack them

Technology

A novel class of therapeutic antibodies for the treatment of a variety of cancers.

Targeted Customers

Physicians, Immune oncology field.

Management personnel

Anat Burkovitz - CEO & Co-Founder

Contact information

Name
Anat Burkovitz
Phone
0545880188
Website
https://www.trojan-bio.com
Country
Israel
Zip
7403626

Tags

AntibodiesBiotechnologyLife SciencesMedTechOncology

Classified Technologies

Biomedicine and pharmaceuticals

Winning details

Route name
Winning year

Technological Incubators 2020
Technological Incubators 2020
2023
Technological Incubators 2020
Technological Incubators 2020
2024